Diagnostics Pipeline: FDA Opens Path for Blood Tests Assessing Genetic Cancer Risk
First marketing authorization of a blood test assessing genetic variants related to cancer opens the door for clearance of similar tests.
Dx Pipeline-lir
Subscribe today for access to
Articles and Reports
Finnish Firm Gets First CE Marking for a COVID-19 Breathalyzer Test
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Exact Sciences Ends Cologuard Co-promotion Partnership with Pfizer
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
The Dx Pipeline: A Roundup of the Month’s Key New Product Launches
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
The Dx Pipeline: A Roundup of the Month’s Key New Product Launches
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
The Dx Pipeline: A Roundup of the Month’s Key New Product Launches
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
The Dx Pipeline
A roundup of the month’s key new product launches
From - Laboratory Industry Report
As usual, genome and sequencing products dominated the diagnostics pipeline last month. Exceptions included rapid diagnostic testing products from…
- « Previous
- 1
- 2
- 3
- 4